Expression of Concern: Clinical and metabolic response to probiotic supplementation in patients with rheumatoid arthritis: A randomized, double-blind, placebo-controlled trial

IF 2.4 4区医学 Q2 RHEUMATOLOGY

International Journal of Rheumatic Diseases Pub Date : 2024-08-27 DOI:10.1111/1756-185X.15299

{"title":"Expression of Concern: Clinical and metabolic response to probiotic supplementation in patients with rheumatoid arthritis: A randomized, double-blind, placebo-controlled trial","authors":"","doi":"10.1111/1756-185X.15299","DOIUrl":null,"url":null,"abstract":"<p>B. Zamani, H. R. Golkar, S. Farshbaf, M. Emadi-Baygi, M. Tajabadi-Ebrahimi, P. Jafari, R Akhavan, M. Taghizadeh, M. R. Memarzadeh, and Z. Asemi, Clinical and metabolic response to probiotic supplementation in patients with rheumatoid arthritis: A randomized, double-blind, placebo-controlled trial, <i>International Journal of Rheumatic Diseases</i> 19, no. 9 (2016): 869–879, https://doi.org/10.1111/1756-185X.12888. This Expression of Concern is for the above article, published online on 02 May 2016 in Wiley Online Library (wileyonlinelibrary.com), and has been published by agreement between the journal Editor-in-Chief, James Cheng-Chung Wei, and John Wiley & Sons Australia, Ltd. The Expression of Concern has been agreed due to concerns raised regarding the integrity of the research and discrepancies in reporting. An investigation has been conducted by the National Committee for Ethics in Biomedical Research Iran, in coordination with Kashan University of Medical Sciences (KAUMS). However, without the verification of clinical records there remain sufficient doubts about the feasibility and integrity of the research undertaken. As a result, the journal has decided to issue an Expression of Concern to alert readers.</p>","PeriodicalId":14330,"journal":{"name":"International Journal of Rheumatic Diseases","volume":null,"pages":null},"PeriodicalIF":2.4000,"publicationDate":"2024-08-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/1756-185X.15299","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Rheumatic Diseases","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/1756-185X.15299","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"RHEUMATOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

B. Zamani, H. R. Golkar, S. Farshbaf, M. Emadi-Baygi, M. Tajabadi-Ebrahimi, P. Jafari, R Akhavan, M. Taghizadeh, M. R. Memarzadeh, and Z. Asemi, Clinical and metabolic response to probiotic supplementation in patients with rheumatoid arthritis: A randomized, double-blind, placebo-controlled trial, International Journal of Rheumatic Diseases 19, no. 9 (2016): 869–879, https://doi.org/10.1111/1756-185X.12888. This Expression of Concern is for the above article, published online on 02 May 2016 in Wiley Online Library (wileyonlinelibrary.com), and has been published by agreement between the journal Editor-in-Chief, James Cheng-Chung Wei, and John Wiley & Sons Australia, Ltd. The Expression of Concern has been agreed due to concerns raised regarding the integrity of the research and discrepancies in reporting. An investigation has been conducted by the National Committee for Ethics in Biomedical Research Iran, in coordination with Kashan University of Medical Sciences (KAUMS). However, without the verification of clinical records there remain sufficient doubts about the feasibility and integrity of the research undertaken. As a result, the journal has decided to issue an Expression of Concern to alert readers.

查看原文本刊更多论文

表达关切：类风湿性关节炎患者对补充益生菌的临床和代谢反应：随机、双盲、安慰剂对照试验。

B.Zamani, H. R. Golkar, S. Farshbaf, M. Emadi-Baygi, M. Tajabadi-Ebrahimi, P. Jafari, R Akhavan, M. Taghizadeh, M. R. Memarzadeh, and Z. Asemi, Clinical and metabolic response to probiotic supplementation in patients with rheumatoid arthritis：随机、双盲、安慰剂对照试验》，《国际风湿病杂志》第 19 期，第 9 号（2016 年）：869–879, https://doi.org/10.1111/1756-185X.12888.本《关注声明》针对的是2016年5月2日在线发表于《威利在线图书馆》（wileyonlinelibrary.com）的上述文章，由期刊主编詹姆斯-魏成忠（James Cheng-Chung Wei）和John Wiley & Sons Australia, Ltd.协议发表。之所以同意发布《关注声明》，是因为有人对研究的完整性和报告中的差异表示担忧。伊朗国家生物医学研究伦理委员会（National Committee for Ethics in Biomedical Research Iran）已与卡尚医科大学（KAUMS）合作开展调查。然而，在没有对临床记录进行核实的情况下，对所开展研究的可行性和完整性仍然存在足够的怀疑。因此，本刊决定发布 "关注声明"，以提醒读者注意。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

International Journal of Rheumatic Diseases RHEUMATOLOGY-

CiteScore

3.70

自引率

4.00%

发文量

362

审稿时长

1 months

期刊介绍： The International Journal of Rheumatic Diseases (formerly APLAR Journal of Rheumatology) is the official journal of the Asia Pacific League of Associations for Rheumatology. The Journal accepts original articles on clinical or experimental research pertinent to the rheumatic diseases, work on connective tissue diseases and other immune and allergic disorders. The acceptance criteria for all papers are the quality and originality of the research and its significance to our readership. Except where otherwise stated, manuscripts are peer reviewed by two anonymous reviewers and the Editor.